- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01907841
The Effect of Ischemic Pre-Conditioning on the Rate of Recovery Following Exercise-Induced Muscle Damage
The Effect of Ischemic Pre-Conditioning on the Rate of Recovery Following Exercise-Induced Muscle Damage: a Randomized Control Trial
Strenuous exercise or exercise involving eccentric muscle contractions can lead to muscle damage and changes in muscle function; this is known as exercise-induced muscle damage (EIMD). It is known that brief, repeated periods of ischemia followed by reperfusion, known as Ischemic Preconditioning (IPC) cause a delay in cell injury in cardiac muscle as well as in various other organs.
Therefore the purpose of this study is to:
- Quantify the use of IPC in recovery following EIMD.
- Identify any effect of IPC during recovery on muscle function
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, TW1 4SX
- St Marys Umiversity College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Physically Active Males
Exclusion Criteria:
- Muscular skeletal disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ischemic Preconditioning
IPC (4 x 5 minute cycles @ 220 mmHg) with 5 min reperfusion between trials.
|
|
Placebo Comparator: Ischemic Preconditioning Placebo
Placebo (4 x 5 minute cycles @ 20mmHg) with 5 minutes between each cycle
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in maximal voluntary contraction
Time Frame: pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Isometric MVC of the participants' dominant knee extensors was assessed using a strain gauge. MVCs were performed for 3 s with a 60 s rest between each repetition. The change in MVC will be determined 24, 48 and 72 hours following pre exercise conditions. |
pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Creatine kinase
Time Frame: pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Plasma CK was determined from an earlobe capillary blood sample. The sample (10 microlitres) was analysed immediately using an semi-automated clinical chemistry analyser. The change in CK will be determined 24, 48 and 72 hours following pre exercise conditions |
pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Change from baseline in Limb girth
Time Frame: pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Mid-thigh and calf circumference was assessed as a measure of limb swelling using an anthropometric tape measure. Both measures were obtained with the participant in a standing position. The change in limb girth will be determined 24, 48 and 72 hours following pre exercise conditions |
pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Chnage from baseline in Vertical jump
Time Frame: pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Vertical jump (VJ) performance was assessed using an electronic timing mat with hands placed on hips and participants dropping down to a self-selected level before jumping maximally. The change in VJ will be determined 24, 48 and 72 hours following pre exercise conditions |
pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Change from baseline in Muscle soreness
Time Frame: pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Muscle soreness - Participants were asked to perform and hold a squat (90° knee angle) whilst they rated their perceived muscle soreness on a 200 mm visual analogue scale. The scale consisted of a line from 0 mm (no pain) to 200 mm (unbearably painful). The change in muscle soreness will be determined 24, 48 and 72 hours following pre exercise conditions |
pre exercise, 24 hours post, 48 hours post and 72 hours post exercise
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IPCEIMD001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise-induced Muscle Damage
-
St Mary's University CollegeNot yet recruitingExercise Induced Muscle Damage
-
Swiss Federal Institute of TechnologyCompletedExercise Induced Muscle DamageSwitzerland
-
Northumbria UniversityCompletedExercise Induced Muscle Damage
-
Northumbria UniversityCompletedExercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino AcidsExercise-induced Muscle Damage
-
Federal University of Health Science of Porto AlegreCompletedFatigue | Exercise-induced Muscle DamageBrazil
-
Université de MontréalCompletedExercise | Nutrition | Damage MuscleCanada
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Antioxidant StatusGreece
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Intracellular Signaling in Skeletal Muscle | Proteasome ActivationGreece
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
Mucos Pharma GmbH & Co. KGCompletedMuscle Soreness | Muscle Injury | Exercise Induced Muscle DamageGermany
Clinical Trials on Ischemic Preconditioning
-
Ulsan University HospitalCompletedContrast Induced Acute Kidney InjuryKorea, Republic of
-
Tartu University HospitalCompletedAtherosclerosis | Stable Angina | Peripheral Artery Disease | Contrast-induced NephropathyEstonia
-
Università Vita-Salute San RaffaeleRecruitingMyocardial Ischemia | SurgeryItaly, Russian Federation, Serbia
-
St. Francis Hospital, New YorkTerminatedCoronary Artery DiseaseUnited States
-
Capital Medical UniversityPeking University First HospitalCompletedCerebral Small Vessel DiseaseChina
-
Azienda Ospedaliera Città della Salute e della...CompletedAcute Kidney InjurySpain, France, Italy
-
St. Josefs-Hospital Wiesbaden GmbHRecruitingAtrial FibrillationGermany
-
Medical University of LodzCompletedRemote Ischemic Preconditioning | Contrast Induced - Acute Kidney InjuryPoland
-
Derince Training and Research HospitalUnknownContrast-induced Nephropathy
-
Hospital for Special Surgery, New YorkUniversity of Massachusetts, WorcesterCompletedPostoperative Pain | Total Knee Arthroplasty | Ischemic PreconditioningUnited States